Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy

(2014) Romain Mathieu et al.   WORLD JOURNAL OF UROLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

(2013) Axel Heidenreich et al.   EUROPEAN UROLOGY

Anti-caveolin-1 Antibodies As Anti-Prostate Cancer Therapeutics

(2012) Shu-Ru Kuo et al.   HYBRIDOMA

Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature

(2010) Giovanni Lughezzani et al.   EUROPEAN UROLOGY

A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006

(2010) Firas Abdollah et al.   EUROPEAN UROLOGY

Functional Analysis of Secreted Caveolin-1 in Mouse Models of Prostate Cancer Progression

(2009) M. Watanabe et al.   MOLECULAR CANCER RESEARCH

The role of caveolin-1 in prostate cancer: clinical implications

(2009) T C Thompson et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer

(2008) Andrea Gallina et al.   BJU INTERNATIONAL

Caveolin-1 in tumor progression: the good, the bad and the ugly

(2008) Jacky G. Goetz et al.   CANCER AND METASTASIS REVIEWS

Utility of Bcl-2, P53, Ki-67, and Caveolin-1 Immunostaining in the Prediction of Biochemical Failure After Radical Prostatectomy in a Japanese Population

(2008) Takahiro Goto et al.   UROLOGY